Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Stop-and-Go FOLFOX4 in 1st Line mCRC
NCT01023633Phase 4Unknown
- Sponsor
- Nanjing Medical University
- Start
- Oct 2009
- Primary completion
- Jan 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of oxaliplatin in colorectal cancer (CRC), sponsored by Nanjing Medical University. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01023633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01023633.